Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $301 | $255 | $283 |
| - Cash | $77 | $88 | $119 | $65 |
| + Debt | $0 | $1 | $1 | $2 |
| Enterprise Value | – | $215 | $137 | $220 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2 | -$3 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$42 | -$41 | -$39 | -$33 |
| % Margin | – | – | – | – |
| Net Income | -$42 | -$37 | -$34 | -$34 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.53 | -0.44 | -0.4 | -0.4 |
| % Growth | -20.5% | -10% | 0% | – |
| Operating Cash Flow | -$40 | -$33 | -$31 | -$30 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$40 | -$33 | -$31 | -$30 |